Musk’s casual Neuralink updates on social media and the company’s failure to publish data go against long standing scientific and ethical protocols and could ultimately stymie progress for all neurotechnology, experts told Forbes.
Neuralink, Musk’s brain interface company that hopes to merge humans with computers, began the first human trial of its technology in January with a view to restoring lost functions like movement and communication to people with paralysis.
Since 2016, Elon Musk’s startup Neuralink has been working on developing a brain chip that will allow users to control devices using only their thoughts. For the first time, it’s been implanted into a human being.
Neuralink confirmed via X, formerly Twitter, that the US$280 million (AU$428 million) funding round was led by Peter Thiel’s Founders Fund.
Musk and Arnault brought along close family members for the meal, an Instagram post revealed.
Neuralink, Elon Musk’s brain implant company, has won approval from the U.S. Food and Drug Administration to start testing its device in humans, one of a growing cadre of neurotech pioneers with goals of merging humans with machines to treat a range of medical conditions such as paralysis, blindness and depression—and enhance existing abilities like memory or […]